Talquetamab‐Related Dysgeusia in Multiple Myeloma Compared to BCMA‐Targeted Bispecifics and High‐Dose Melphalan. - Fleischer, Anna; Roll, Magdalena; Frenking, Jan H.; Panther, Franziska; Gelbrich, Götz; Strunz, Patrick‐Pascal; Riedhammer, Christine; Peter, Jessica; Mersi, Julia; Waldschmidt, Johannes; Kortüm, Martin; Einsele, Hermann; et al. (Cancer Medicine, 2025)